Home » ETF » IBB

IBB - iShares Nasdaq Biotechnology ETF

Stock Price: $151.58 USD -1.68 (-1.10%)
Updated Apr 19, 2021 4:00 PM EDT - Market closed
After-hours: $151.50 -0.08 (-0.05%) Apr 19, 6:16 PM
Assets $10.15B
NAV $153.29
Expense Ratio 0.46%
PE Ratio 20.82
Beta (5Y) 0.97
Dividend (ttm) $0.39
Dividend Yield 0.25%
Ex-Dividend Date Mar 25, 2021
1-Year Return -
Trading Day April 19
Last Price $151.58
Previous Close $153.26
Change ($) -1.68
Change (%) -1.10%
Day's Open 152.52
Day's Range 150.68 - 153.67
Day's Volume 2,030,248
52-Week Range 119.37 - 173.89

Fund Description

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Asset Class
Equity
Sector
Biotech
Region
Global
Inception Date
Feb 5, 2001
Exchange
NASDAQ
Ticker Symbol
IBB
Index Tracked
NASDAQ Biotechnology Index

Top 10 Holdings

45.23% of assets
NameSymbolWeight
AmgenAMGN9.30%
Gilead SciencesGILD7.01%
IlluminaILMN4.97%
Vertex PharmaceuticalsVRTX4.71%
ModernaMRNA4.47%
Regeneron PharmaceuticalsREGN4.32%
BiogenBIIB3.47%
Alexion PharmaceuticalsALXN2.85%
SeagenSGEN2.23%
AstraZenecaAZN1.89%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Mar 25, 2021$0.131059Mar 31, 2021
Dec 14, 2020$0.0655Dec 18, 2020
Sep 23, 2020$0.063Sep 29, 2020
Jun 15, 2020$0.127Jun 19, 2020
Mar 25, 2020$0.0554Mar 31, 2020
Dec 16, 2019$0.0578Dec 20, 2019
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

Other tickers mentioned: AZN, BBH, BNTX, BTEC, FBT, MRNA, NVAX ...
1 week ago - Zacks Investment Research

At this point, investors are best off with a pick-and-choose strategy.

3 weeks ago - The Motley Fool

Biotechnology sector-related exchange traded funds could stumble in the near-term as increased regulatory scrutiny weighs on drugmakers. Among the hardest hit areas of Tuesday, the ALPS Medical Breakthr...

Other tickers mentioned: SBIO, XBI
3 weeks ago - ETF Trends

Biotech is ‘the superhero of the pandemic': investor

YouTube video

Antoine Papiernik, managing partner at Sofinnova Partners, joins Yahoo Finance to discuss trends in biotech and impacts the pandemic had on scientific discoveries.

Other tickers mentioned: XBI
3 weeks ago - Yahoo Finance

Short-term investors may not see the long-term potential.

Other tickers mentioned: NVAX, OCGN, VIR, XBI
4 weeks ago - The Motley Fool

Stocks: Biotech and the outlook for vaccine stocks over the next 3-5 years

YouTube video

Yahoo Finance's Julie Hyman and Myles Udland spoke to Oppenheimer & Co. Analyst Hartaj Singh about the outlook for vaccine stocks.

Other tickers mentioned: XBI
1 month ago - Yahoo Finance

Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.

Other tickers mentioned: BOTZ, CLIX, CLOU, FMAT, IBUY, JNJ, ROBT ...
1 month ago - Zacks Investment Research

Biotech ETFs are climbing Wednesday as the Food and Drug Administration's staff endorsed Johnson & Johnson's coronavirus vaccine for emergency use, a key step in offering a third vaccination to the U.S....

Other tickers mentioned: BTEC
1 month ago - ETF Trends

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high.

Other tickers mentioned: BSX, XBI
2 months ago - InvestorPlace

Biotechnology sector-related exchange traded funds strengthened after Illumina (NasdaqGS: ILMN) announced better-than-expected quarterly earnings and an optimistic 2021 outlook. On Friday, the VanEck Ve...

Other tickers mentioned: BBH
2 months ago - ETF Trends

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: BBH, XBI
2 months ago - Zacks Investment Research

The Biden portfolio

YouTube video

The stocks most likely to get a boost from the new administration. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman, and Steve Grasso.

Other tickers mentioned: CAT, DKNG, EEM, GWPH, OLN, TJX, TSE ...
2 months ago - CNBC Television

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

Other tickers mentioned: ARKG, BBH, BNTX, BTEC, CNCR, FBT, PBE ...
3 months ago - Zacks Investment Research

We highlight some ETF areas that held their ground and gained popularity among investors amid the coronavirus crisis.

Other tickers mentioned: CLIX, CLOU, ESGU, ESPO, HERO, IBUY, SKYY ...
3 months ago - Zacks Investment Research

Due to lucrative risk/reward setups and heightened fundamental demand, many active traders will be watching biotech stocks.

Other tickers mentioned: ILMN, MRNA
3 months ago - Investopedia

The Nasdaq clocked double-digit gains for two years in a row in 2020. It may log double-digit gains in 2021 all over again if the virus scenario does not improve as fast as expected.

Other tickers mentioned: IWM, ONEQ, QQEW, QQQ, SPY, TDIV
3 months ago - Zacks Investment Research

Here we highlight some ETFs that can help investors make the most of the favorable investing opportunities amid the coronavirus crisis.

Other tickers mentioned: ESPO, IBUY, MTUM, VGT, XLE
4 months ago - Zacks Investment Research

Why this health-care strategist says the sector will rally into 2021

YouTube video

CNBC's Kelly Evans discusses the healthcare sector as well as biotech and pharma stocks and why the rally in these names can continue into 2021 with Jefferies' Jared Holz.

Other tickers mentioned: XBI
4 months ago - CNBC Television

Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K. bec...

Other tickers mentioned: CNCR, XBI
4 months ago - ETF Trends

Those of you who are new to the Daily, you probably noticed the references to the Economic Modern Family. Mish developed one index and five sectors as the nucleus of the Family to help you and herself s...

Other tickers mentioned: SMH
4 months ago - See It Market

November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday, pharm...

Other tickers mentioned: BBH, XBI
4 months ago - ETF Trends

Biotech stocks are likely to remain in focus through year end amid news surrounding COVID-19 vaccines and treatments.

Other tickers mentioned: PBE
4 months ago - Investopedia

Healthcare stocks and ETFs are continuing to outperform as investors are optimistic about an upcoming vaccine for the coronavirus, which has been a blight on the globe since early this year. There has b...

Other tickers mentioned: BBH, CNCR
4 months ago - ETF Trends

The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.

Other tickers mentioned: CARZ, FBT, JETS, KBWB, KRE, PEJ, XBI ...
4 months ago - Zacks Investment Research

President Trump issues two 'groundbreaking' rules to lower drug prices

YouTube video

President Trump speaks on two new rules that will limit the price of drugs in the U.S. One rule will require discounts to be passed to patients. The second will require drugs for Medicare to be based on...

Other tickers mentioned: ANTM, HCA, UHS
4 months ago - CNBC Television

Biotech ETFs are getting a boost along with stocks on Monday thanks to Moderna, which announced that its initial phase three trial data reveals a coronavirus vaccine that is over 94% effective. Shares o...

5 months ago - ETF Trends

Monday saw stocks and index ETFs surge, after the announcement from Pfizer that the pharmaceutical giant had a vaccine candidate with an over 90% effectiveness in clinical trials. Now another biotech, M...

Other tickers mentioned: BBH, CNCR
5 months ago - ETF Trends

Biotech companies need capital, but challenge is finding high quality management teams: Cowen CEO

YouTube video

On Monday, Pfizer announced a successful phase 3 trial, showing the vaccine to be more than 90 percent effective. This comes as the FDA gave emergency use authorization to Eli Lilly's antibody treatment.

Other tickers mentioned: XBI
5 months ago - CNBC Television

Final Trades: MRVL, EEM, IBB & CHWY

YouTube video

The traders make their final trades of the week.

Other tickers mentioned: CHWY, EEM, MRVL
5 months ago - CNBC Television

Easing worries regarding major policy changes are driving the relief rally in the healthcare and biotech spaces in the post-election period.

Other tickers mentioned: PJP, PPH, VHT, XBI, XLV
5 months ago - Zacks Investment Research

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their third-quarter earnings releases amid the coronavirus crisis.

Other tickers mentioned: BBH, XBI
5 months ago - Zacks Investment Research

If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?

Other tickers mentioned: DXCM, GILD, IDXX, MRNA, PFE, QDEL
5 months ago - InvestorPlace

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare th...

Other tickers mentioned: IDNA
5 months ago - ETF Trends

Institutional investors top biotech analyst on race for Covid treatment

YouTube video

Umer Raffat, Evercore ISI biotech analyst, on coronavirus treatments as cases start to rise around the country. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman...

Other tickers mentioned: AZN, GILD, MRK, MRNA, PFE
5 months ago - CNBC Television

In spite of no passing government stimulus, mixed economic data, rising covid cases and a wild pre election season, for the first time since we can remember, our core stock market ETFs are brushing off ...

Other tickers mentioned: IWM, IYT, KRE, SMH, XRT
6 months ago - See It Market

Regardless of lockdowns or otherwise, these biotech stocks are positioned to rally strongly in the weeks and months ahead The post 3 Biotech Stocks to Buy Right Now appeared first on InvestorPlace. More...

Other tickers mentioned: CRSP, MRNA
6 months ago - InvestorPlace

Vertex Pharmaceuticals (VRTX) sold off on heavy volume after discontinuing trials of a promising liver disease treatment.

Other tickers mentioned: VRTX
6 months ago - Investopedia

With less than a month until the election, and Democratic challenger Joe Biden opening up a wide lead, two market analysts lay out how to trade the politically sensitive health-care sector.

Other tickers mentioned: IHI
6 months ago - CNBC

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

Other tickers mentioned: ARKG, BBH, PBE, XBI
6 months ago - Zacks Investment Research

Here we discuss ETFs that can be a good addition for enhanced portfolio returns in the fourth quarter of 2020.

Other tickers mentioned: ESPO, IBUY, ICLN, VGT
6 months ago - Zacks Investment Research

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

Other tickers mentioned: ARKG, BBH, PBE, XBI
6 months ago - Zacks Investment Research

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

Other tickers mentioned: ARKG, BBH, XBI
6 months ago - Zacks Investment Research

Here are the ETFs to watch as biotech names bounce

YouTube video

Kevin O'Leary, O'Shares ETFs chairman, and Jim Lowell, Advisor Investments, join 'ETF Edge' on 'The Fast Money Halftime Report' discuss the bounce in biotech ETFs following news that President Trump is ...

6 months ago - CNBC Television

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

Other tickers mentioned: ARKG, BBH, FBT, XBI
6 months ago - Zacks Investment Research

Health care is again at a political crossroads heading into the U.S. presidential election. Gina Sanchez of Chantico Global and Craig Johnson of Piper Sandler discuss the potential winners and losers in...

Other tickers mentioned: IHI, XLV
6 months ago - CNBC

With companies like Pfizer (PFE) giving possible hope for an end of year vaccine and a recent gap up in Nasdaq Biotechnology ETF (IBB), now could be a good time to keep an eye on newer issues in this se...

7 months ago - See It Market

The novel coronavirus is weighing on the market, but these four biotech stocks can survive. Here's what you need to know to profit now.

Other tickers mentioned: IRWD, XBI, XLV
7 months ago - InvestorPlace

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Other tickers mentioned: ARKG, BETZ, EDOC, IHI, VHT, WFH, XBI ...
7 months ago - ETFcom

The Final Trade: IBB, NFLX, PLNT & PTON

YouTube video

The traders offer their final stock picks of the week.

Other tickers mentioned: NFLX, PTON, PLNT
7 months ago - CNBC Television

Coronavirus vaccine breakdown: The race for a COVID-19 vaccine

YouTube video

Meghan Fitzgerald Columbia University Health care Policy Professor discusses COVID-19 vaccine devlopment.

Other tickers mentioned: XBI
7 months ago - Yahoo Finance